SEARCH

SEARCH BY CITATION

References

  • AGUILAR-BRYAN, L., NICHOLS, C.G., WECHSLER, S.W., CLEMENT IV, J.P., BOYD III, A.E., GONZÁLEZ, G., HERRERA-SOSA, H., NGUY, K., BRYAN, J. & NELSON, D.A. (1995). Cloning of the β cell high-affinity sulfonylurea receptor: a regulator of insulin secretion. Science, 268, 423426.
  • AKIYOSHI, M., KAKEI, M., NAKAZAKI, M. & TANAKA, H. (1995). A new hypoglycemic agent, A-4166, inhibits ATP-sensitive potassium channels in rat pancreatic β-cells. Am. J. Physiol., 268, E185E193.
  • ANDERSON, M.P., BERGER, H.A., RICH, D.P., GREGORY, R.J., SMITH, A.E. & WELSH, M.J. (1991). Nucleoside triphosphates are required to open the CFTR chloride channel. Cell, 67, 775784.
  • ASHCROFT, F.M. & GRIBBLE, F.M. (1998). Correlating structure and function in ATP-sensitive K+ channels. Trends Neurosci., 21, 288294.
  • ASHCROFT, S.J.H. & ASHCROFT, F.M. (1990). Properties and functions of ATP-sensitive K-channels. Cell. Signal., 2, 197214.
  • BENHAM, C.D., BOLTON, T.B., LANG, R.J. & TAKEWAKI, T. (1985). The mechanism of action of Ba2+ and TEA on single Ca2+-activated K+-channels in arterial and intestinal smooth muscle cell membranes. Pflügers Arch., 403, 120127.
  • BROWN, G.R. & FOUBISTER, A.J. (1984). Receptor binding sites of hypoglycemic sulfonylureas and related [(acylamino)alkyl]benzoic acids. J. Med. Chem., 27, 7981.
  • EDWARDS, G. & WESTON, A.H. (1993). The pharmacology of ATP-sensitive potassium channels. Annu. Rev. Pharmacol. Toxicol., 33, 597637.
  • FUHLENDORFF, J. (1998). Molecular identification of a specific binding site (36 kDa) for repaglinide. Diabetes, 47, supplement 1, A416.
  • FUHLENDORFF, J., RORSMAN, P., KOFOD, H., BRAND, C.L., ROLIN, B., MACKAY, P., SHYMKO, R. & CARR, R.D. (1998). Stimulation of insulin release by repaglinide and glibenclamide involves both common and distinct processes. Diabetes, 47, 345351.
  • GABRIEL, S.E., BRIGMAN, K.N., KOLLER, B.H., BOUCHER, R.C. & STUTTS, M.J. (1994). Cystic fibrosis heterozygote resistance to cholera toxin in the cystic fibrosis mouse model. Science, 266, 107109.
  • GADSBY, D.C., NAGEL, G. & HWANG, T.-C. (1995). The CFTR chloride channel of mammalian heart. Annu. Rev. Physiol., 57, 387416.
  • GERICH, J.E. (1989). Oral hypoglycemic agents. New Engl. J. Med., 321, 12311245.
  • GILLIS, K.D., GEE, W.M., HAMMOUD, A., MCDANIEL, M.L., FALKE, L.C. & MISLER, S. (1989). Effects of sulfonamides on a metabolite-regulated ATPi-sensitive K+ channel in rat pancreatic B-cells. Am. J. Physiol., 257, C1119C1127.
  • GRIBBLE, F.M., TUCKER, S.J. & ASHCROFT, F.M. (1997). The interaction of nucleotides with the tolbutamide block of cloned ATP-sensitive K+ channel currents expressed in Xenopus oocytes: a reinterpretation. J. Physiol., 504, 3545.
  • GROMADA, J., DISSING, S., KOFOD, H. & FRØKJÆR-JENSEN, J. (1995). Effects of the hypoglycaemic drugs repaglinide and glibenclamide on ATP-sensitive potassium-channels and cytosolic calcium levels in β TC3 cells and rat pancreatic beta cells. Diabetologia, 38, 10251032.
  • HAMILL, O.P., MARTY, A., NEHER, E., SAKMANN, B. & SIGWORTH, F.J. (1981). Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers Arch., 391, 85100.
  • HANRAHAN, J.W., TABCHARANI, J.A., CHANG, X.-B. & RIORDAN, J.R. (1994). A secretory Cl channel from epithelial cells studied in heterologous expression systems. Adv. Comp. Environ. Physiol., 19, 193220.
  • HYDE, S.C., EMSLEY, P., HARTSHORN, M.J., MIMMACK, M.M., GILEADI, U., PEARCE, S.R., GALLAGHER, M.P., GILL, D.R., HUBBARD, R.E. & HIGGINS, C.F. (1990). Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport. Nature, 346, 362365.
  • INAGAKI, N., GONOI, T., CLEMENT IV, J.P., NAMBA, N., INAZAWA, J., GONZALEZ, G., AGUILAR-BRYAN, L., SEINO, S. & BRYAN, J. (1995). Reconstitution of IKATP: an inward rectifier subunit plus the sulfonylurea receptor. Science, 270, 11661170.
  • JENTSCH, T.J. & GÜNTHER, W. (1997). Chloride channels: an emerging molecular picture. BioEssays, 19, 117126.
  • LANSDELL, K.A., DELANEY, S.J., LUNN, D.P., THOMSON, S.A., SHEPPARD, D.N. & WAINWRIGHT, B.J. (1998). Comparison of the gating behaviour of human and murine cystic fibrosis transmembrane conductance regulator Cl channels expressed in mammalian cells. J. Physiol., 508, 379392.
  • LINSDELL, P. & HANRAHAN, J.W. (1996a). Disulphonic stilbene block of cystic fibrosis transmembrane conductance regulator Cl channels expressed in a mammalian cell line and its regulation by a critical pore residue. J. Physiol., 496, 687693.
  • LINSDELL, P. & HANRAHAN, J.W. (1996b). Flickery block of single CFTR chloride channels by intracellular anions and osmolytes. Am. J. Physiol., 271, C628C634.
  • MARSHALL, J., FANG, S., OSTEDGAARD, L.S., O'RIORDAN, C.R., FERRARA, D., AMARA, J.F., HOPPE IV, H., SCHEULE, R.K., WELSH, M.J., SMITH, A.E. & CHENG, S.H. (1994). Stoichiometry of recombinant cystic fibrosis transmembrane conductance regulator in epithelial cells and its functional reconstitution into cells in vitro. J. Biol. Chem., 269, 29872995.
  • MCCARTY, N.A., MCDONOUGH, S., COHEN, B.N., RIORDAN, J.R., DAVIDSON, N. & LESTER, H.A. (1993). Voltage-dependent block of the cystic fibrosis transmembrane conductance regulator Cl channel by two closely related arylaminobenzoates. J. Gen. Physiol., 102, 123.
  • MCDONOUGH, S., DAVIDSON, N., LESTER, H.A. & MCCARTY, N.A. (1994). Novel pore-lining residues in CFTR that govern permeation and open-channel block. Neuron, 13, 623634.
  • MOGAMI, H., SHIBATA, H., NOBUSAWA, R., OHNOTA, H., SATOU, F., MIYAZAKI, J.-I. & KOJIMA, I. (1994). Inhibition of ATP-sensitive K+ channel by a non-sulfonylurea compound KAD-1229 in a pancreatic β-cell line, MIN 6 cell. Eur. J. Pharmacol., 269, 293298.
  • NEHER, E. & STEINBACH, J.H. (1978). Local anaesthetics transiently block currents through single acetylcholine-receptor channels. J. Physiol., 277, 153176.
  • PANTEN, U., BURGFELD, J., GOERKE, F., RENNICKE, M., SCHWANSTECHER, M., WALLASCH, A., ZÜNKLER, B.J. & LENZEN, S. (1989). Control of insulin secretion by sulfonylureas, meglitinide and diazoxide in relation to their binding to the sulfonylurea receptor in pancreatic islets. Biochem. Pharmacol., 38, 12171229.
  • PANTEN, U., SCHWANSTECHER, M. & SCHWANSTECHER, C. (1996). Sulfonylurea receptors and mechanism of sulfonylurea action. Exp. Clin. Endocrinol., 104, 19.
  • RIORDAN, J.R., ROMMENS, J.M., KEREM, B.-S., ALON, N., ROZMAHEL, R., GRZELCZAK, Z., ZIELENSKI, J., LOK, S., PLAVSIC, N., CHOU, J.-L., DRUMM, M.L., IANNUZZI, M.C., COLLINS, F.S. & TSUI, L.-C. (1989). Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science, 245, 10661073.
  • SCHULTZ, B.D., DEROOS, A.D.G., VENGLARIK, C.J., SINGH, A.K., FRIZZELL, R.A. & BRIDGES, R.J. (1996). Glibenclamide blockade of CFTR chloride channels. Am. J. Physiol., 271, L192L200.
  • SCHWANSTECHER, M., SCHWANSTECHER, C., DICKEL, C., CHUDZIAK, F., MOSHIRI, A. & PANTEN, U. (1994). Location of the sulphonylurea receptor at the cytoplasmic face of the β-cell membrane. Br. J. Pharmacol., 113, 903911.
  • SHEPPARD, D.N. & ROBINSON, K.A. (1997). Mechanism of glibenclamide inhibition of cystic fibrosis transmembrane conductance regulator Cl channels expressed in a murine cell line. J. Physiol., 503, 333346.
  • SHEPPARD, D.N. & WELSH, M.J. (1992). Effect of ATP-sensitive K+ channel regulators on cystic fibrosis transmembrane conductance regulator chloride currents. J. Gen. Physiol., 100, 573591.
  • STURGESS, N.C., KOZLOWSKI, R.Z., CARRINGTON, C.A., HALES, C.N. & ASHFORD, M.L.J. (1988). Effects of sulphonylureas and diazoxide on insulin secretion and nucleotide-sensitive channels in an insulin-secreting cell line. Br. J. Pharmacol., 95, 8394.
  • SULLIVAN, L.P., WALLACE, D.P. & GRANTHAM, J.J. (1998). Epithelial transport in polycystic kidney disease. Physiol. Rev., 78, 11651191.
  • VENGLARIK, C.J., SCHULTZ, B.D., DEROOS, A.D.G., SINGH, A.K. & BRIDGES, R.J. (1996). Tolbutamide causes open channel blockade of cystic fibrosis transmembrane conductance regulator Cl channels. Biophys. J., 70, 26962703.
  • WALSH, K.B., LONG, K.J. & SHEN, X. (1999). Structural and ionic determinants of 5-nitro-2-(3-phenylpropylamino)-benzoic acid block of the CFTR chloride channel. Br. J. Pharmacol., 127, 369376.
  • WELSH, M.J., TSUI, L.-C., BOAT, T.F. & BEAUDET, A.L. (1995). Cystic fibrosis. In The Metabolic and Molecular Basis of Inherited Disease, ed. Scriver, C.R., Beaudet, A.L., Sly, W.S. & Valle, D. pp. 37993876. New York: McGraw-Hill Inc.
  • WINTER, M.C., SHEPPARD, D.N., CARSON, M.R. & WELSH, M.J. (1994). Effect of ATP concentration on CFTR Cl channels: a kinetic analysis of channel regulation. Biophys. J., 66, 13981403.
  • WOODHULL, A.M. (1973). Ionic blockage of sodium channels in nerve. J. Gen. Physiol., 61, 687708.